Packages of Care for Attention-Deficit Hyperactivity Disorder in Low- and Middle-Income Countries
article has not abstract
Vyšlo v časopise:
Packages of Care for Attention-Deficit Hyperactivity Disorder in Low- and Middle-Income Countries. PLoS Med 7(2): e32767. doi:10.1371/journal.pmed.1000235
Kategorie:
Neglected Diseases
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pmed.1000235
Souhrn
article has not abstract
Zdroje
1. American Psychiatric Association (APA) 2004 Diagnostic and Statistical Manual of Mental Disorders: Fourth Edition Text Revision (DSM-IV-TR). Washington DC APA
2. World Health Organization (WHO) 1992 The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines. Geneva WHO
3. BuitelaarJK
BartonJ
DanckaertsM
GillbergC
HazellPL
2006 A comparison of North American versus non-North American AD/HD study populations. Europ Child Adolesc Psychiat 15 177 181
4. FaraoneS
SergeantJ
GillbergC
BidermanJ
2003 The worldwide prevalence of AD/HD: is it an American condition? World Psychiat 2 104 113
5. RohdeLA
SzobotC
PolanczykG
SchmitzM
MartinsS
Tramontina S. 2005 Attention-deficit/hyperactivity disorder in a diverse culture: Do research and clinical findings support the notion of a cultural construct for the disorder? Biol Psychiat 57 1436 1441
6. CaninoG
AlegríaM
2008 Psychiatric diagnosis - is it universal or relative to culture? J Child Psychol Psychiatry 49 237 50
7. FlisherAJ
HatherillS
DhansayY
Swartz L. 2007 ADHD, Culture and the DSM-V (abstract). J Child Adolesc Mental Health 19 173
8. PolanczykG
De LimaMS
HortaBL
BiedermanJ
RohdeLA
2007 The worldwide prevalence of ADHD: A systematic review and metaregression analysis. Am J Psychiat 164 942 948
9. BiedermanJ
2005 Attention-deficit/hyperactivity disorder: A selective overview. Biol Psychiatry 57 1215 1220
10. BiedermanJ
FaraoneSV
2005 Attention deficit hyperactivity disorder. Lancet 366 237 248
11. PatelV
LundC
HatherillS
PlagersonS
CorrigallJ
(in press) Social Determinants of Mental Disorders.
BlasE
Sivasankara KurupA
Priority public health conditions: from learning to action on social determinants of health Geneva WHO
12. CollettB
OhanJ
MyersK
2009 Ten-Year Review of Rating Scales. V: Scales Assesing Attention-Deficit/Hyperactivity Disorder. J Am Acad Child Adolsc Psychiat 42 1015 1037
13. PelhamW
FabianoG
MassettiG
2005 Evidence-Based Assessment of Attention Deficit Hyperactivity Disorder in Children and Adolescents. J Clin Child Adolesc Psychol 34 449 476
14. SmithK
CorkumP
2007 Systematic Review of Measures Used to Diagnose Attention-Deficit/Hyperactivity Disorder in Research on Preschool Children. Topics Early Child Spec Educ 27 164
15. ShafferD
FisherP
LucasCP
DulcanMK
Schwab-StoneME
2000 NIMH Diagnostic Interview Schedule for Children Version IV (NIMH DISC-IV): Description, differences from previous versions, and reliability of some common diagnoses. J Am Acad Child Adolesc Psychiatry 39 28 38
16. LeungPW
LeeCC
TangCP
HungSF
KwongSL
2005 Test-retest reliability of the Chinese version of the Diagnostic Interview Schedule for Children-Version 4 (DISC-IV). J Child Psychol Psychiatry 46 1135 1138
17. FlisherAJ
LundC
SorsdahlK
RobertsonB
2009 Test-Retest Reliability of the Xhosa Version of the Diagnostic Interview Schedule for Children (abstract). J Child Adolesc Mental Health 21 88
18. BritoG
PintoR
LinsM
1995 A behavioral assessment scale for attention deficit disorder in Brazilian children based on DSM-IIIR criteria. J Abnorm Child Psychol 23 509 520
19. LampertTL
PolanczykG
TramontinaS
MardiniV
RohdeLA
2004 Diagnostic performance of the CBCL-Attention Problem Scale as a screening measure in a sample of Brazilian children with AD/HD. J Atten Disord 8 63 71
20. VitielloB
2001 Methylphenidate in the treatment of children with attention-deficit hyperactivity disorder. Can Med Assoc J 165 1505 1506
21. BanaschewskiT
CoghillD
SantoshP
ZuddasA
AshersonP
2006 Long – acting medications for the hyperkinetic disorders: a systematic review and European treatment guideline. Eur Child Adolesc Psychiatry 15 476 495
22. KarandeS
2005 Attention deficit hyperactivity disorder – a review for family physicians. Indian J Med Sci 59 546 555
23. KratochvilCJ
EggerH
GreenhillLL
McGoughJJ
2006 Pharmacological management of preschool ADHD. J Am Acad Child Adolesc Psychiatry 45 115 118
24. TaylorE
DöpfnerM
SergeantJ
AshersonP
BanaschewskiT
2004 A. European clinical guidelines for hyperkinetic disorder – first upgrade. Eur Child Adolesc Psychiatry 13 Suppl 1 17 130
25. American Academy of Child and Adolescent Psychiatry 2007 Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 46 894 921
26. GreenhillLL
KollinsS
AbikoffH
McCrackenJ
RiddleM
2006 Efficacy and safety of immediate-release methylphenidate treatment for preschoolers with ADHD. J Am Acad Child Adolesc Psychiatry 45 1284 1293
27. WigalT
GreenhillLL
ChuangS
McGoughJ
VitielloB
2006 Safety and tolerability of methylphenidate in preschool children with ADHD. J Am Acad Child Adolesc Psychiatry 45 1294 1303
28. MichelsonD
AllenAJ
BusnerJ
CasatC
DunnD
2002 Once-daily atomoxetine treatment for children and adolescents with attention deficit hyperactivity disorder: a randomized, placebo-controlled study. Am J Psychiatry 159 1896 1901
29. MichelsonD
FariesD
WernickeJ
KelseyD
KendrickF
2001 Atomoxetine in the treatment of children and adolescents with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, dose-response study. Pediatrics 108 1 9
30. WilensT
McBurnettK
SteinM
LernerM
SpencerT
WolraichM
2005 ADHD treatment with once daily OROS methylphenidate treatment: final results from a long term open-label study. J Am Acad Child Adolesc Psychiatry 44 1015 1023
31. WilensT
GaoH
ThomasonC
GelowitzD
KratochvilC
NewcornJ
2004 Longer term treatment with atomoxetine in adolescents with ADHD. Scientific Proceedings of the American Psychiatric Association, No. 578, New York, May
32. MTA Cooperative Group 2004 National Institute of Mental Health Multimodal Treatment Study of ADHD follow-up: changes in effectiveness and growth after the end of treatment. Pediatrics 113 762 769
33. VitielloB
SevereJB
GreenhillLL
ArnoldLE
AbikoffHB
2001 Methylphenidate dosage for children with ADHD over time under controlled conditions: lessons from the MTA. J Am Acad Child Adolesc Psychiatry 40 188 196
34. GreenhillLL
NewcornJH
GaoH
FeldmanPD
2007 Effect of two different methods of initiating atomoxetine on the adverse event profile of atomoxetine. J Am Acad Child Adolesc Psychiatry 45 566 572
35. WilensTE
FaraoneSV
BiedermanJ
GunawardeneS
2003 Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature. Pediatrics 111 179 185
36. MolinaBS
HinshawSP
SwansonJM
ArnoldLE
VitielloB
2009 The MTA at 8 years: prospective follow-up of children treated for combined-type ADHD in a multisite study. J Am Acad Child Adolesc Psychiatry 48 484 500
37. KleinRG
AbikoffH
HechtmanL
WeissG
2004 Design and rationale of controlled study of long-term methylphenidate and multimodal psychosocial treatment in children with ADHD. J Am Acad Child Adolesc Psychiatry 43 792 801
38. The MTA Cooperative Group 1999 A 14-month randomized clinical trial of treatment strategies for attention deficit/hyperactivity disorder (AD/HD). Arch Gen Psychiatry 56 1073 1086
39. HechtmanL
AbikoffH
KleinRG
WeissG
RespitzC
2004 Academic achievement and emotional status of children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment. J Amer Acad Child Adolesc Psychiatry 43 812 819
40. AbikoffH
HechtmanL
KleinRG
WeissG
FleissK
2004 Symptomatic improvement in children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment. J Amer Acad Child Adolesc Psychiatry 43 802 811
41. MTA Cooperative Group 2004 National Institute of Mental Health Multimodal Treatment Study of AD/HD Follow-up: 24-Month Outcomes of Treatment Strategies for Attention-Deficit/Hyperactivity Disorder. Pediatrics 113 754 761
42. ConnersCK
EpsteinJN
MarchJS
AngoldA
WellsKC
2001 Multimodal treatment of ADHD in the MTA: An alternative outcome analysis. J Am Acad Child Adolesc Psychiatry 40 159 167
43. MarchJS
SwansonJM
ArnoldLE
HozaB
ConnersCH
2000 Anxiety as a predictor and outcome variable in the multimodal treatment study of children with ADHD MTA. J Abnorm Child Psychol 28 527 541
44. JensenPS
HinshawSP
SwansonJM
GreenhillLL
ConnersCK
2001 Findings from the NIMH Multimodal Treatment Study of ADHD MTA: implications and applications for primary care providers. J Dev Behav Pediatr 22 60 73
45. ArnoldLE
ElliotM
SachsL
BirdH
KraemerHC
2003 Effects of ethnicity on treatment attendance, stimulant response/dose, and 14-month outcome in ADHD. J Consult Clin Psychol 71 713 727
46. MTA Cooperative Group 1999 Moderators and mediators of treatment response for children with attention deficit hyperactivity disorder: the MTA Study. Arch Gen Psychiatry 56 1088 1096
47. ChronisA
JonesH
RaggiVL
2006 Evidence-based psychosocial treatments for children and adolescents with attention-deficit/hyperactivity disorder. Clin Psychol Review 26 486 502
48. FabianoG
PelhamWE
ColesEK
GnagyEM
Chronis-TuscanoA
2009 A meta-analysis of behavioural treatments for attention-deficit/hyperactivity disorder. Clin Psychol Rev 29 129 140
49. ToplakME
ConnorsL
ShusterJ
KnezevicB
ParksS
2008 Review of cognitive, cognitive-behavioral, and neural-based interventions for Attention-Deficit/Hyperactivity Disorder (AD/HD). Clin Psychol Rev 28 801 823
50. AbikoffH
1985 Efficacy of Cognitive Training Interventions in Hyperactive Children: A Critical Review. Clin Psychol Rev 5 479 512
51. BjornstadGJ
MontgomeryP
2009 Family therapy for attention-deficit disorder or attention-deficit/hyperactivity disorders in children and adolescents. Cochrane Database of Systematic Reviews. Art.No CD005042 doi:10.1002/14651858.CD005042.pub2
52. CorcoranJ
DattaloP
2006 Parent Involvement in Treatment for AD/HD: A Meta-Analysis of the Published Studies. Res Soc Work Pract 16 561 570
53. GhanizadehA
ShahrivarFZ
2005 The Effect of Parent Management Training on Children with Attention Deficit Hyperactivity Disorder. J Child Adolesc Mental Health 17 31 34
54. SaugataB
AniruddhaD
1996 Parent training in children with attention deficit hyperactivity disorder: An integrated approach for greater effectiveness. Ind J Clin Psychol 23 184 191
55. WalkerJS
ColemanD
LeeJ
SquirePN
FriesenBJ
2008 Children's stigmatization of childhood depression and AD/HD: magnitude and demographic variation in a national sample. J Am Acad Child Adolesc Psychiatry 47 912 920
56. HovenCW
DoanT
MusaGJ
JaliashviliT
DuarteCS
2008 WPA Awarness Task Force. Worldwide child and adolescent mental health begins with awareness: a preliminary assessment in nine countries. Int Rev Psychiatry 20 261 270
57. Graeff-MartinsAS
FlamentMF
FayyadJ
TyanoS
JensenP
2008 Diffusion of efficacious interventions for children and adolescents with mental health problems. J Child Psychol Psychiatry 49 335 352
58. JitendraAK
DupaulGJ
SomekiF
TrescoKE
2008 Enhancing academic achievement for children with Attention-Deficit Hyperactivity Disorder: evidence from school-based intervention research. Dev Disabil Res Rev 14 325 330
59. PatelV
SimonG
ChowdharyN
KaayaS
ArayaR
2009 Packages of Care for Depression in Low- and Middle-Income Countries. PLoS Med 6 e1000159 doi:10.1371/journal.pmed.1000159
60. RushtonJL
FantKE
ClarkSJ
2004 Use of practice guidelines in the primary care of children with attention-deficit/hyperactivity disorder. Pediatrics 11 e23 28
61. EpsteinJN
RabinerD
JohnsonDE
FitzgeraldDP
ChrismanA
2007 Improving attention-deficit/hyperactivity disorder treatment outcomes through use of a collaborative consultation treatment service by community-based pediatricians: A cluster randomized trial. Arch Pediatr Adolesc Med 161 835 840
Štítky
Interné lekárstvoČlánok vyšiel v časopise
PLOS Medicine
2010 Číslo 2
- Hydroresponzivní krytí v epitelizační fázi hojení rány
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Metamizol v liečbe pooperačnej bolesti u detí do 6 rokov veku
- Co dělat při intoleranci statinů?
- Statiny indukovaná myopatie: Jak na diferenciální diagnostiku?
Najčítanejšie v tomto čísle
- Packages of Care for Attention-Deficit Hyperactivity Disorder in Low- and Middle-Income Countries
- Measuring hsCRP—An Important Part of a Comprehensive Risk Profile or a Clinically Redundant Practice?
- Developing Global Maps of the Dominant Vectors of Human Malaria
- Guidance for Developers of Health Research Reporting Guidelines